Sermorelin Dosage Guide: Protocols, Timing & What the Research Shows
Sermorelin is the only GHRH analog with a history of FDA approval, having been cleared for pediatric GH deficiency in 1990 and withdrawn in 2008 for manufacturing reasons — not safety concerns.[6] Standard adult dosing is 200-500mcg SubQ once daily at bedtime. Its key advantage over HGH: it preserves the pituitary's natural feedback loop rather than bypassing it.
Quick Reference
Standard dose
200-500mcg
Frequency
Once daily
Timing
Before bed
Half-life
11-12 min
Regulatory status: Category 1 — available through 503A compounding pharmacies with a valid prescription. Full registry →
What Is Sermorelin and How Does It Work?
Sermorelin (GHRH 1-29) is a synthetic analog of growth hormone-releasing hormone comprising the first 29 amino acids of the naturally occurring GHRH molecule — the shortest fragment that retains full bioactivity.[1] It binds to GHRH receptors on the anterior pituitary gland, stimulating the transcription and pulsatile release of endogenous growth hormone.
Unlike recombinant HGH, which directly replaces growth hormone and bypasses the body's feedback systems, Sermorelin works upstream — it asks the pituitary to produce more of its own GH. This preserves the natural regulatory loop involving somatostatin and IGF-1, which modulates GH output and prevents excessive secretion.[2]
GH secretion naturally declines by approximately 14% per decade after peak secretion in young adulthood — a process called somatopause. By age 60, GH output is roughly 25% of what it was at 20.[3] Sermorelin is used off-label in adults to partially restore this decline through physiologic rather than pharmacologic means.
Why the pituitary feedback loop matters: When you inject HGH directly, IGF-1 rises and somatostatin suppresses further GH release — but the exogenous GH keeps coming regardless. Sermorelin works within this system. If IGF-1 is elevated, somatostatin increases, and the pituitary responds less to Sermorelin. This self-regulating mechanism significantly reduces the risk of excess GH-related side effects (joint pain, edema, insulin resistance) that are more common with direct HGH use.[2]
What Is the Right Sermorelin Dosage?
The standard adult dosing range is 200-500mcg injected subcutaneously once daily. Most protocols start at the lower end (200-300mcg) and titrate upward based on IGF-1 lab results at 3 months and clinical response.[7]
Sermorelin's extremely short half-life of 11-12 minutes means it acts quickly at the receptor level and is rapidly cleared from circulation.[1] The GH release it triggers, however, persists for several hours after the peptide itself has cleared. This makes once-daily dosing sufficient for most protocols.
Starting Protocol (weeks 1-4)
Allow the pituitary to adapt. Start conservative, assess tolerance.
Dose
200mcg
Frequency
Once daily
Timing
Before bed
Maintenance Protocol (weeks 5+)
Titrate based on IGF-1 labs and symptom response. 300-500mcg is the typical therapeutic range.
Dose
300-500mcg
Frequency
Once daily
Labs
IGF-1 at 3 months
On dose-response: Research suggests pituitary receptor saturation occurs around 400-500mcg in most individuals. Doses above this threshold extend the duration of elevated GH slightly but do not produce proportionally higher GH release. IGF-1 labs at 3 months are the most reliable guide for dose optimization.[5]
Why Bedtime? The Timing Rationale Explained
Sermorelin is almost universally administered 30-60 minutes before sleep, and this is not arbitrary. GH secretion in humans follows a strong circadian rhythm, with the largest natural pulse occurring during slow-wave (deep) sleep — typically 1-2 hours after sleep onset.[4]
Administering Sermorelin before bed amplifies this natural peak rather than creating an off-cycle stimulus. The result is a GH pulse that is both larger and more physiologically timed than daytime administration would produce. For the same reason, eating a large meal or consuming carbohydrates within 2-3 hours of injection should be avoided — insulin elevation suppresses GH release.
✅ Bedtime injection
- •Amplifies natural GH peak during slow-wave sleep
- •Aligns with physiologic circadian rhythm
- •GH released while fasted (post-dinner)
- •Repair and recovery occur during sleep
- •This is how all clinical studies dose it
❌ Avoid
- •Injecting after a large meal or carb-heavy food
- •Alcohol within 3 hours (suppresses GH release)
- •Daytime injection without clinical reason
- •Injecting immediately before intense exercise (GH already elevated)
- •Missing the pre-sleep window consistently
Sermorelin vs HGH: Key Differences
| Sermorelin | Recombinant HGH | |
|---|---|---|
| Mechanism | Stimulates pituitary to produce own GH | Directly replaces GH |
| GH release pattern | Pulsatile (physiologic) | Continuous (supraphysiologic) |
| Feedback loop | Preserved — somatostatin still regulates | Bypassed — no self-regulation |
| Half-life | 11-12 minutes | ~3-5 hours (SubQ) |
| FDA history | Approved 1990, withdrawn 2008 (not safety) | Approved, restricted to specific indications |
| Prescription required | Yes — compounding pharmacy | Yes — strict indications |
| Side effect profile | Lower — self-regulating mechanism | Higher — dose-dependent risk |
| IGF-1 elevation | Moderate, within normal range | Can be supraphysiologic |
| Pituitary health | Preserves and may improve function | Suppresses endogenous production |
Sources: Ishida et al. (2020)[1]; Walker (2006)[2]; Sigalos & Pastuszak (2018)[5]
Sermorelin Dosing Reference by Indication
| Use Case | Dose | Frequency | Timing | Route | Cycle |
|---|---|---|---|---|---|
| Standard / Anti-Aging | 200-300mcg | Once daily | 30-60 min before bed | SubQ abdomen | 3-6 months |
| GH Deficiency (off-label) | 300-500mcg | Once daily | 30-60 min before bed | SubQ abdomen | 6-12 months |
| Body Composition / Recovery | 300-500mcg | Once daily | 30-60 min before bed | SubQ abdomen | 3-6 months |
| GLP-1 Muscle Preservation | 200-300mcg | Once daily | 30-60 min before bed | SubQ abdomen | Duration of GLP-1 protocol |
| Stacked with Ipamorelin | 200-300mcg Sermorelin + 200-300mcg Ipamorelin | Once daily (or 2x daily) | Before bed (+ morning if 2x) | SubQ (can mix) | 3-6 months |
Off-label adult dosing. Sermorelin requires a prescription from a licensed physician through a 503A compounding pharmacy.
What Stacks Well with Sermorelin?
Sermorelin works through the GHRH receptor. The most effective combinations pair it with compounds that work through complementary GH-axis pathways.
Sermorelin + Ipamorelin
The most widely used GH optimization stack. Sermorelin activates the GHRH receptor, driving GH transcription and release. Ipamorelin activates the ghrelin receptor (GHS-R), amplifying the GH pulse amplitude without raising cortisol or prolactin. Together they produce synergistic GH release significantly greater than either alone.[5]
Sermorelin 200-300mcg + Ipamorelin 200-300mcg — once daily before bed. Can mix in same syringe.
Sermorelin + CJC-1295 (no DAC)
CJC-1295 (no DAC) is a modified GHRH analog with a longer half-life than Sermorelin, amplifying GH pulse amplitude. When stacked, Sermorelin provides the initial stimulus and CJC-1295 extends the GH release window. This combination is used in clinical protocols for more robust GH elevation.
Sermorelin 200mcg + CJC-1295 100-200mcg — once daily before bed. Can mix in same syringe.
Sermorelin on GLP-1 Protocols
GLP-1 receptor agonists (Semaglutide, Tirzepatide) can reduce muscle mass by lowering caloric intake and indirectly decreasing GH/IGF-1 axis signaling. Sermorelin counteracts this by restoring physiologic GH pulses, supporting protein synthesis, muscle recovery, and insulin sensitivity during aggressive weight loss.[7]
See the GLP-1 Defense Stack for the full evidence-graded protocol.
How to Reconstitute Sermorelin
Sermorelin typically comes as lyophilized powder in vials of 2mg, 3mg, or 6mg. Add bacteriostatic water (BAC water) to achieve a concentration that gives a clean draw on a U-100 insulin syringe.
Common example: 3mg vial + 1.5ml BAC water
Concentration
2mg/ml
1.5ml in 3mg vial
300mcg dose
15 units
U-100 insulin syringe
500mcg dose
25 units
U-100 insulin syringe
Frequently Asked Questions
What is the standard Sermorelin dosage?
200-500mcg SubQ once daily at bedtime. Start at 200-300mcg and titrate based on IGF-1 labs at 3 months. Bedtime dosing aligns with the body's natural GH secretion peak during slow-wave sleep.
How long does Sermorelin take to work?
The half-life is 11-12 minutes — it acts quickly at the pituitary level. Measurable changes in body composition, sleep quality, and recovery typically require 3-6 months of consistent use. IGF-1 should be tested at baseline and at 3 months.
Can Sermorelin be stacked with Ipamorelin?
Yes — this is the most widely used GH optimization stack. Sermorelin activates the GHRH receptor. Ipamorelin activates the ghrelin receptor. Complementary mechanisms produce synergistic GH release significantly greater than either alone. Same syringe, same timing, once daily before bed.
Does Sermorelin require post-cycle therapy?
No. Sermorelin stimulates the pituitary's own GH production rather than suppressing it. There is no HPTA suppression and no PCT required. The pituitary continues normal function throughout and after the protocol.
Why was Sermorelin withdrawn from the market?
Sermorelin (brand name Geref) was withdrawn by the manufacturer in 2008 due to difficulties in manufacturing the active ingredient — not for safety or efficacy reasons. The FDA confirmed this formally in 2013. It remains available through 503A compounding pharmacies with a valid prescription.
References
- [1]Ishida J, Saitoh M, Ebner N, Springer J, Anker SD, von Haehling S. Growth hormone secretagogues: history, mechanism of action, and clinical development. JCSM Rapid Communications. 2020;3(1):25-37.
- [2]Walker RF. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clinical Interventions in Aging. 2006;1(4):307-308. PMID 18046908.
- [3]Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-157. PMID 18031173.
- [4]Khorram O, Laughlin GA, Yen SS. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. Journal of Clinical Endocrinology & Metabolism. 1997;82(5):1472-1479.
- [5]Sigalos JT, Pastuszak AW. The safety and efficacy of growth hormone secretagogues. Sexual Medicine Reviews. 2018;6(1):45-53.
- [6]U.S. Food & Drug Administration. Determination that GEREF (Sermorelin acetate) injection was not withdrawn from sale for reasons of safety or effectiveness. Federal Register. 2013.
- [7]Cook DM, Yuen KC, Biller BM, Kemp SF, Vance ML; American Association of Clinical Endocrinologists. Medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients — 2009 update. Endocrine Practice. 2009;15(Suppl 2):1-29.
- [8]Chang Y, Huang R, Zhai Y, et al. A potentially effective drug for patients with recurrent glioma: sermorelin. Annals of Translational Medicine. 2021;9(5):406.
Citations are provided for informational context. This article does not reproduce copyrighted content from these sources.
Share this article